The Sarcoma Biology and Outcome Project

Recruiting now

Conditions studied: Sarcoma, Malignant Mesenchymoma, Sarcoma of Bone and Connective Tissue

In brief

SarcBOP - An interdisciplinary and translational registry SarcBOP aims to establish a database that integrates every aspect possibly relevant to sarcoma treatment and research. SarcBOP thus will not be limited to specific questions or patient groups, but instead will build a comprehensive database including clinical, pathologic, and radiologic information, multi-layered molecular data, and patient-reported outcomes, combined with a dedicated biobank for tissue samples and liquid biopsies. As the study integrates seamlessly with the clinical activities of the Heidelberg Sarcoma Center, the Molecular Diagnostics Program of NCT Heidelberg, including the NCT/DKTK MASTER Program, and with the NCT Trial Center, including the PMO Clinical Trials Program, SarcBOP will generate a comprehensive and continuously growing resource for clinicians, researchers, and, finally, patients.

Key facts

Study ID: NCT04758325
Run by: Prof. Dr. Richard F Schlenk
People needed: 3000
Starts: 2019-07-23
Expected to finish: 2032-12-31
Last updated by the study team: 2025-03-25

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Suspected or proven diagnosis of soft-tissue or bone sarcoma (STBS)
Age ≥12 years
Ability to understand nature and individual consequences of the registry
Written informed consent
Subjects who are physically or mentally capable of giving consent

You may not qualify if…

Severe neurological or psychiatric disorder interfering with the ability to give written informed consent

Where it is running

National Center for Tumour Diseases, University Hospital Heidelberg — Heidelberg, Baden-Wurttemberg, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.